Fibroblast growth factor receptor 1 (FGFR1) is a downstream pathway of the MYB gene; therefore, target FGFR1 could inhibit one of the main molecular dysregulation pathways in the pathogenesis of ACC. The gene discussed is FGFR1; the disease is adrenal cortex carcinoma.